Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Feb 13, 2014
Insider Transaction Report
Form 4
Nisi Rudolph
Director
Transactions
- Purchase
Common Stock
2014-02-07$4.94/sh+20,000$98,742→ 23,500 total
Footnotes (2)
- [F1]The reporting person's purchase of GALE common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's sale of 20,000 shares of GALE common stock at an average price of $7.111514 per share on January 17, 2014. The reporting person has agreed to pay to GALE $43,487.78, representing the full amount of the profit realized in connection with the short-swing transaction.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.9151 to $4.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.